Packers’ Rodgers Defends Being Unvaccinated, Decries ‘Woke Culture’
(Bloomberg) -- Aaron Rodgers has no regrets about not being vaccinated.
In a Friday appearance on the Pat McAfee Show, the Green Bay Packers quarterback said not getting vaccinated was the best choice for his body.
“I'm not some sort of anti-vax, flat-Earther, I am somebody who is a critical thinker,” Rodgers said. “I believe strongly in bodily autonomy and the ability to make choices for your body, not to have to acquiesce to some woke culture or crazed group of individuals who say you have to do something. Health is not a one-size-fits-all for everybody.”
The three-time MVP said he is allergic to an ingredient that's in mRNA vaccines and that he had “heard of multiple people who had had adverse events” around getting the Johnson & Johnson vaccine.
Instead, Rodgers said he went through an immunization process. He defended his response earlier in the year when asked if he had been vaccinated and responded by saying “Yeah I've been immunized” and defended other players on the Packers who had not been vaccinated, saying he's not going to “judge those guys” but did not say he was among them.
“It wasn't some sort of ruse or lie, it was the truth,” Rodgers said Friday. Had there been a follow-up question, he would have further explained his feeling on the topic, he claimed.
In the interview Friday, Rodgers said he unsuccessfully petitioned to have his immunization treatment classify him as a vaccinated player and that it was denied. He described measures non-vaccinated players have to follow under the National Football League's protocols as “draconian” and “not based in science.”
Rodgers said he first experienced symptoms beginning Tuesday night and tested positive on Wednesday.
“I consulted with a now good friend of mine Joe Rogan after he got Covid and I've been doing a lot of the stuff that he recommended in his podcasts and on the phone to me and I'm going to have the best immunity possible now,” Rodgers said, adding that he's been taking monoclonal antibodies, ivermectin and zinc, among other things.
©2021 Bloomberg L.P.
-
One El Nino, India Can Handle. Two Could Break The Granary
India's grain stocks can absorb one bad year, but a second El Nino could drain the buffer in two to three years, economists say.
-
India's Troika Of Good Luck | Joining The Dots
As Jensen Huang's exit drags Nvidia down, a cooling AI trade and resilient earnings have revived investor interest in India. A likely RBI rate hike looms.
-
Talking Points This Week: Leadership Shock At Nvidia, Earnings Strength, And The Fog Over Hormuz
The Anthropic IPO pricing and first trading day, Nvidia's upcoming earnings, and any fresh signals from Iran will set the tone for the following week.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.